SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001113148-20-000008
Filing Date
2020-03-17
Accepted
2020-03-17 08:00:01
Documents
3
Period of Report
2020-03-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a317208k.htm 8-K 38219
2 EXHIBIT 99.1 pressrelease.htm EX-99.1 12828
3 GRAPHIC headera03.jpg GRAPHIC 24003
  Complete submission text file 0001113148-20-000008.txt   85732
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 20719280
SIC: 2834 Pharmaceutical Preparations